Bleichroeder LP’s MaxCyte MXCT Stock Holding History

Bleichroeder LP’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-250,000	Closed	-$522K	–	78
2025 Q2	$522K	Hold	250,000	–	–	0.13%	43
2025 Q1	$675K	Hold	250,000	–	–	0.18%	36
2024 Q4	$1.01M	Hold	250,000	–	–	0.25%	32
2024 Q3	$980K	Hold	250,000	–	–	0.26%	33
2024 Q2	$1.02M	Hold	250,000	–	–	0.3%	33
2024 Q1	$1.08M	Hold	250,000	–	–	0.27%	32
2023 Q4	$1.12M	Hold	250,000	–	–	0.25%	30
2023 Q3	$778K	Hold	250,000	–	–	0.19%	28
2023 Q2	$1.11M	Hold	250,000	–	–	0.23%	35
2023 Q1	$1.2M	Hold	250,000	–	–	0.26%	30
2022 Q4	$1.32M	Hold	250,000	–	–	0.29%	32
2022 Q3	$1.62M	Hold	250,000	–	–	0.34%	32
2022 Q2	$1.16M	Hold	250,000	–	–	0.24%	38
2022 Q1	$1.76M	Hold	250,000	–	–	0.31%	38
2021 Q4	$2.54M	Hold	250,000	–	–	0.4%	38
2021 Q3	$3.03M	Buy	+250,000	New	+$3.77M	0.49%	36

Other funds holding MXCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

AIM

AXA Investment Managers Puteaux, France $37.1B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bleichroeder LP's MXCT Position: Q3 2025 in Review

Bleichroeder LP sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 250,000 shares — an estimated $522K sold.

Bleichroeder LP first reported a position in MXCT in Q3 2021 and held it in 16 quarters. The position peaked at $3.03M in Q3 2021. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

Bleichroeder LP reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
Bleichroeder LP sold 250,000 MaxCyte shares in Q3 2025, an estimated $522K.
Bleichroeder LP first reported a position in MaxCyte in Q3 2021 and held it in 16 quarters.
Bleichroeder LP's MaxCyte position peaked at $3.03M in Q3 2021.
112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Bleichroeder LP's 13F filing for Q3 2025, filed 14 Nov 2025.